Response to treatment with Medgenics' Epodure Biopump, which is used to deliver therapeutic proteins, is dose-dependent, a study has suggested. In the ongoing phase I/II trial, the pumps are being used to manufacture erythropoietin (EPO) in anaemia patients, who cannot produce it themselves. The ...
Please Login to read the full article.
